Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence-accelerated mouse

Journal of Lipid Research

Volumn 44, Issue 4, 2003, Pages 762-769

  Umezawa, Makiko ^a   Tatematsu, Kenjiro ^b   Korenaga, Tatsumi ^d   Fu, Xiaoying ^d   Matushita, Takatoshi ^c   Okuyama, Harumi ^b   Hosokawa, Masanori ^c   Takeda, Toshio ^c   Higuchi, Keiichi ^d  

^a KOSHIEN UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein A II; Apolipoprotein A II amyloid fibril; High density lipoprotein

Indexed keywords

AMYLOID; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; FAT; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SAFFLOWER OIL;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BUTTER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; FAT INTAKE; HEART; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER; MALE; MODULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SENESCENCE; SKIN; SPLEEN; STATISTICAL SIGNIFICANCE; STOMACH; TISSUE DISTRIBUTION;

AGING, PREMATURE; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEIN A-II; BUTTER; DIETARY FATS; DISEASE MODELS, ANIMAL; FISH OILS; LIPIDS; LIPOPROTEINS; MALE; MICE; SAFFLOWER OIL; SENILE PLAQUES; TISSUE DISTRIBUTION;

EID: 0142010513     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200405-JLR200     Document Type: Article

References (48)

1. Takeda, T., Hosokawa, S. Takeshita, M. Irio, K. Higuchi, T. Matsushita, Y. Tomita, K. Yasurira, H. Hamamoto, K. Shimizu, M. Ishii, and T. Yamamuro. 1981. A new murine model of accelerated senescence. Mech. Aging Dev. 17: 183-194.
2. Matsumura, A., K. Higuchi, K. Shimizu, M. Hosokawa, K. Hashimoto, K. Yasuhira, and T. Takeda. 1982. A novel amyloid fibril protein isolated from senescence accelerated mice. Lab. Invest. 47: 270-275.
3. Takeshita, S., M. Hosokawa, M. Irino, K. Higuchi, K. Simizu, K. Yasuhira, and T Takeda. 1982. Spontaneous age-associated amyloidosis in Senescence-Accelerated mouse (SAM). Mech. Ageing Dev. 20: 13-23.
4. SAM) demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab. Invest. 48: 231-240.
5. SAM is a low molecular weight apoprotein of high density lipoprotein. J. Exp. Med. 158: 1600-1614.
6. Yonezu, T., K. Higuchi, S. Tsunasawa, S. Takagi, F. Sakiyama, T. and Takeda. 1986. High homology is present in the primary structures between murine senile amyloid protein (ASSAM) and human apolipoprotein A-II. FEBS Lett. 203: 149-152.
7. Higuchi, K., T. Yonezu, S. Tsunasawa, F. Sakiyama, and T. Takeda. 1986. The single proline-glutamine substitution at position 5 enhance the potency of amyloid fibril formation of murine apoA-II. FEBS Lett. 207: 23-27.
8. SAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J. Biol. Chem. 261: 12834-12840.
9. Higuchi, K., K. Kitagawa, H. Naiki, K. Hanada, M. Hosokawa, and T. Takeda. 1991. Polymorphism of Apolioprotein A-II (ApoA-II) among inbred strains of mice: Relationship between the molecular type of ApoA-II and mouse senile amyloidosis. Biochem. J. 279: 427-433.
10. Higuchi, K., H. Naiki, K. Kitagawa, M. Hosokawa, and T. Takeda. 1991. Mouse senile amyloidosis: ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Arch. B Cell Pathol. 60: 231-239.
11. Naiki, H., K. Higuchi, A. Shimada, T. Takeda, and K. Nakakura. 1993. Genetic analysis of murine senile amyloidosis. Lab. Invest. 68: 332-337.
12. Higuchi, K. 1997. Genetic characterization of senescence-accelerated mouse (SAM). Exp. Gerontol. 32: 129-138.
13. Halminski, M. A., J. B. Marsh, and E. H. Harrison. 1991. Differential effects of fish oil, safflower oil and palm oil fatty acid oxidation and glycerolipid synthesis in rat liver. J. Nutr. 121: 1554-1561.
14. Choi, Y. S., S. Goto, I. Ikeda, and M. Sugano. 1989. Effects of dietary (n-3) polyunsaturated fatty acids on cholesterol synthesis and degradation in rats of different ages. Lipids. 24: 45-50.
15. Hang, A., and A. T. Hostmark. 1987. Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. J. Nutr. 117: 1011-1017.
16. Cox, C., J. Mann, W. Sutherland, A. Chisholm, and M. Skeaff. 1995. Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with moderately elevated cholesterol levels. J. Lipid. Res. 36: 1787-1795.
17. Williams, R. C., E. S. Cathcart, E. Calkins, G. L. Fite, J. B. Rubio, and A. S. Cohen. 1965. Secondary amyloidosis in lepromatous leprosy: Possible relations of diet and environment. Ann. Intern. Med. 62: 1000-1007.
18. Cathcart, E. S., C. A. Leslie, S. N. Meydani, and K. C. Hayes. 1987. A fish oil diet retards experimental amyloidosis, modulates lymphocyte function, and decreases macrophage arachidonate metabolism in mice. J. Immunol. 139: 1850-1854.
19. Kohno, A., Y. Yonezu, M. Matsusuta, M. Irino, K. Higuchi, K. Higuchi, D.Takeshita, M. Hosokawa, and T. Takeda. 1985. Chronic food restriction modulates the advance of senescence in the Senescence Accerelated Mouse (SAM). J. Nutr. 115: 1259-1266.
20. Wolozin, B., W. Kellman, P. Ruosseau, G. G. Celesia, and G. Siegel. 2000. Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57: 1439-1443.
21. Jick, H., G. L. Zornberg, S. S. Jick, S. Seshadri, and D. A. Drachman. 2000. Statins and the risk of dementia. Lancet. 356: 1627-1631.
22. Fassbender, K., M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. V. Bergmann, M. Hennerici, K. Beyreuther, and T. Hartmann. 2001. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. PNAS. 98: 5856-5861.
23. Umezawa, M., T. Takeda, K. Kogishi, K. Higuchi, T. Matushita, J. Wang, T. Chiba, and M. Hosokawa. 2000. Serum lipid concentrations and mean life span are modulated by dietary polyunsaturated fatty acids in the senescence-accelerated mouse. J. Nutr. 130: 221-227.
24. Umezawa, M., K. Hanada, K. Naiki, W. H. Chen, M. Hosokawa, and T. Takeda. 1990. Effect of dietary restriction on age-related immune dysfunction in the Senescence Accelerated Mouse (SAM). J. Nutr. 120: 1393-1400.
25. Puchtler, H., F. Sweat, and M. Levine. 1962. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10: 355-364.
26. Fujihara, S.,J. E. Balow, J. C. Costa, and G. G. Glenner. 1980. Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method. Lab. Invest. 43: 358-365.
27. Takeda, T., K. Higuchi, and M. Hosokawa. 1988. ASSAM amyloidosis is present in aging mice of many strains, not only in SAM. In Amyloid and Amyloidosis: Proceedings of the Fifth International Symposium on Amyloidosis, October, 1987, Hakone, Japan. T. Isobe and S. Araki, editors. Plenum Press, New York, NY. 985-690.
28. Higuchi, K., M. Hosokawa, and T. Takeda. 1999. Senescence-accelerated mouse. Methods Enzymol. 309: 674-686.
29. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. 37: 911-917.
30. Yamamoto, N., M. Saito, A. Moriuchi, M. Nomura, and H. Okuyama. 1987. Effect of the dietary α-linolenate/linoleate balance on lipid compositions and learning ability of rats. J. Lipid Res. 28: 144-151.
31. Higuchi, K., H. Naiki, K. Kitagawa, H. Kitado, K. Kogishi, T. Matsushita, and T. Takeda. 1995. Apolioprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II. Lab. Invest. 72: 75-82.
32. c) reduces the plasma level and the size of high density lipoprotein. FEBS Lett. 317: 207-210.
33. Beer, F., A. Goetz, E. Schreiber, and G. Paumgartner. 1993. Effect of dietary n-3 versus n-6 polyunsaturated fatty acids on hepatic excretion of cholesterol in the hamster J. Lipid Res. 34: 1275-1284.
34. Ikeda, I., K. Wakamatsu, A. Inayoshi, K. Imaizumi, M. Sugano, and K. Yazawa. 1994. α-linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats. J. Nutr. 124: 1898-1906.
35. Roach, P. D., A. M. Kambouris, R. P. Trimble, D. L. Topping, and P. J. Nestel. 1987. The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rats. FEBS Lett. 222: 159-162.
36. Purcell-Huynh, D. A., A. Weinreb, L. W. Castellani, M. Mehrabian, M. H. Doolittle, and A. J. Lusis. 1995. Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach. J. Clin. Invest. 96: 1845-1858.
37. Chiba, T., K. Kogishi, J. Wang, C. Xia, T. Matsushita, J. Miyazaki, I. Saito, M. Hosokawa, and K. Higuchi. 1999. Mouse senile amyloid deposition is suppressed by adenovirus-mediated overexpression of amyloid resistant apolipoprotein A-II. Am. J. Pathol. 155: 1319-1326.
38. Ahn, Y. S., D. Smith, J. Osada, Z. Li, E. J. Schaefer, and J. M. Ordovas. 1994. Dietary fat saturation affects apolipoprotein gene expression and high density lipoprotein size distribution in golden syrian hamsters. J. Nutr. 124: 2147-2155.
39. Doolittle, M. H., R. C. LeBoeuf, C. H. Warden, L. M. Bee, and A. J. Lusis. 1990. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J. Biol. Chem. 265: 16380-16388.
40. Mehrabian, M., and A. J. Lusis. 1992. Candidate genes and processes in atherosclerosis. In Molecular Genetics of Coronary Artery Disease. A. Lusis, J. I. Rotter, and R. S. Sparkes, editors. Karger, Basel. 363-418.
41. Babiak, J., F. T. Lindgren, and L. L. Rudel. 1988. Effects of saturated and polyunsaturated dietary fat on the concentration of HDL subpopulation in African green monkeys. Arteriosclerosis. 8: 22-32.
42. Naiki, N., K. Higuchi, T. Yonezu, M. Hosokawa, and T. Takeda. 1988. Metabolism of senile amyloid precursor and amyloidogenesis: Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse. Am. J. Pathol. 130: 579-587.
43. Westermark, G. T., D. F. Steiner, S. Gebre-Medhin, U. Engstrom, and P. Westermark. 2000. Pro islet amyloid polypeptide (ProIAPP) immunoreactivity in the islets of Langerhans. Ups. J. Med. Sci. 105: 97-106.
44. Simons, M., P. Keller, J. Dichgans, and J. B. Schulz. 2001. Cholesterol and Alzheimer's disease. Is there a link? Neurology. 57: 1089-1093.
45. Kojro, E., G. Gimple, S. Lammich, W. März, and F. Fahrenholz. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effects on the α-secretase ADAM 10. Proc. Natl. Acad. Sci. USA. 98: 5815-5820.
46. Wolozin, B. 2001. A fluid connection: cholesterol and Aβ. PNAS. 98: 5371-5373.
47. Berdanier, C. D. 1992. Fatty acids and membrane function. In Fatty Acids in Foods and Their Health Implications. C. K. Chow, editor. Marcel Dekker, New York. 531-544.
48. Li, J. J. and P. W. Mcadam. 1984. Human amyloid P component: an elastase inhibitor. Scan. J. Immunol. 20: 219-223.